Polymorphisms of HLA-DR and - DQ genes in Japanese patients with bullous pemphigoid

Journal of Dermatology

Volumn 27, Issue 3, 2000, Pages 149-156

  Okazaki, Aiko ^a   Miyagawa, Sachiko ^a   Yamashina, Yukio ^a   Kitamura, Wataru ^a   Shirai, Toshihiko ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Bullous pemphigoid; HLA class II genes

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; BULLOUS SKIN DISEASE; CLINICAL ARTICLE; ETHNIC GROUP; FEMALE; GENETIC POLYMORPHISM; HLA SYSTEM; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; PEMPHIGOID;

EID: 0034073038     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2000.tb02141.x     Document Type: Article

References (35)

1. Jordon RE, Beutner EH, Witebsky E, Blumental G, Hale WLC, Lever WF: Basement membrane zone antibodies in bullous pemphigoid, J Am Med Assoc, 200: 751-756, 1967.
2. Stanley JR, Hawlwy-Nelson P, Yuspa SH, Shevach EM, Katz SI: Characterization of bullous pemphigoid antigen: A unique basement membrane protein of stratified squamous epithelia, Cell, 24: 897-903, 1981.
3. Mutasim DF, Takahashi Y, Labib RS, Anhalt GJ, Patel HP, Diaz LA: A pool of bullous pemphigoid antigen is intracellular and associated with the basal cell cytoskeleton-hemidesmosome complex, J Invest Dermatol, 84: 47-53, 1985.
4. Regnier M, Vaigot P, Michel S, Prunieras M: Localization of bullous pemphigoid antigen (BPA) in isolated human keratinocytes, J Invest Dermatol, 85: 187-190, 1985.
5. Büdinger L, Borradori L, Yee C, et al: Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls, J Clin Invest, 102: 2082-2089, 1998.
6. Nepom GT, Erlich H: MHC class II molecules and autoimmunity, Annu Rev Immunol, 9: 493-525, 1991.
7. Yamashina Y, Miyagawa A, Kawatsu T, et al: Polymorphisms of HLA class II genes in Japanese patients with pemphigus vulgaris, Tissue Antigens, 52: 74-77, 1998.
8. Seignalet J, Guillot B, Guilhou JJ, Meynadier J: Probable association between HLA-DR5 and bullous pemphigoid, Tissue Antigens, 30: 190-191, 1987.
9. Delgado JC, Turbay D, Yunis E, et al: A common major histocompatibility complex class II allele HLA-DQB1*0301 is present in clinical variants of pemphigoid, Proc Natl Acad Sci USA, 93: 8569-8571, 1996.
10. Miyagawa S, Iida T, Hachisuka H, Yamashina Y, Shirai T: Epidermolysis bullosa acquisita with oesophagel stenosis, Br J Dermatol, 127: 172-176, 1992.
11. Miyagawa S, Amagai M, Niizeki H, et al: HLA-DRB1 polymorphisms and autoimmune responses to desmogleins in Japanese patients with pemphigus, Tissue Antigens, 54: 333-340, 1999.
12. Yasunaga S, Kimura A, Hamaguchi K, Ronningen S, Sasazuki T: Different contribution of HLA-DR and -DQ genes in susceptibility and resistance to insulin-dependent diabetes mellitus (IDDM), Tissue Antigens, 47: 37-48, 1996.
13. Kaneshige T, Hashimoto M, Kinoshita T, et al: Haplotypic diversity of DQA1*03 and *05 sub-types differing at amino acid residue 160 encoded in the third exon in 2215 Japanese individuals, Tissue Antigens, 49: 46-52, 1997.
14. Hashimoto M, Kinoshita M, Yamasaki M, et al: Gene frequencies and haplotypic associations within the HLA region in 916 unrelated Japanese individuals, Tissue Antigens, 44: 166-173, 1994.
15. Miyagawa S, Shinohara K, Kidoguchi K, et al: Neonatal lupus erythematosus: Haplotypic analysis of HLA class II alleles in child/mother pairs, Arthritis Rheum 40: 982-983, 1997.
16. Marsh SGE, Bodmer JG: HLA class II region nucleotide sequences, 1995, Tissue Antigens, 45: 258-280, 1995.
17. Bodmer JG, Marsh SGE, Albert ED, et al: Nomenclature for factors of the HLA system, 1996, Hum Immunol, 53: 98-128, 1997.
18. Marsh SG: Nomenclature for factors of the HLA system, update April 1998, Tissue Antigens, 52: 300, 1998.
19. Banfield CC, Wojnarowska F, Allen J, George S, Venning VA, Welsh KI: The association of HLA-DQ7 with bullous pemphigoid is restricted to men, Br J Dermatol, 138: 1085-1090, 1998.
20. Yeastman N, Sachs J, Bottazzo GF: Autoimmunity-towards the year 2001, Immunol Today, 13: 239-240, 1992.
21. Todd JA, Acha-Orbea H, Bell JI, et al: A molecular basis for MHC class II-associated autoimmunity, Science, 240: 1003-1009, 1988.
22. Theofilopoulos AN: The basis of autoimmunity: Part II. Genetic predisposition, Immunol Today, 16: 150-159, 1995.
23. Ahmed AR, Foster S, Zaltas M, et al: Association of DQw7 (DQB1*0301) with ocular cicatricial pemphigoid, Proc Natl Acad Sci USA, 88: 11579-11582, 1991.
24. Yunis JJ, Mobini N, Yunis EJ, et al: Common major histocompatibility complex class II markers in clinical variants of cicatricial pemphigoid, Proc Natl Acad Sci USA, 91: 7747-7751, 1994.
25. Chan LS, Hammerberg C, Cooper KD: Significantly increased occurrence of HLA-DQB1*0301 allele in patients with ocular cicatricial pemphigoid, J Invest Dermatol, 108: 129-132, 1997.
26. Morrison LH, Labib RS, Zone JJ, Diaz LA, Anhalt GJ: Herpes gestationis autoantibodies recognize a 180-kD human epidermal antigen, J Clin Invest, 81: 2023-2026, 1988.
27. Giudice GJ, Emery DJ, Zelickson BD, Anhalt GJ, Liu Z, Diaz LA: Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site of the BP180 ectodomain, J Immunol, 151: 5742-5750, 1993.
28. Shornick JK, Stastny P, Gilliam JN: High frequency of histocompatibility antigens HLA-DR3 and DR4 in herpes gestationis, J Clin Invest, 68: 553-555, 1981.
29. Holmes RC, Black MM, Dann J, James DC, Bhogal B: A comparative study of toxic erythema of pregnancy and herpes gestationis, Br J Dermatol, 106: 499-510, 1982.
30. Shornick JK, Jenkins RE, Artlett CM, et al: Class II MHC typing in pemphigoid gestationis, Clin Exp Dermatol, 20: 123-126, 1995.
31. García-González E, Castro-Llamas J, Karchmer S, et al: Class II major histocompatibility complex typing across the ethnic barrier in pemphigoid gestationis. A study in Mexicans, Int J Dermatol, 38: 46-51, 1999.
32. Bernard P, Prost C, Durepaire N, Basset-Seguin N, Didierjean L, Saurat JH: The major cicatricial pemphigoid antigen is a 180-kD protein that shows immunologic cross-reactivities with the bullous pemphigoid antigen, J Invest Dermatol, 99: 174-179, 1992.
33. Balding SD, Prost C, Diaz LA, et al: Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180 extracellular domain, J Invest Dermatol, 106: 141-146, 1996.
34. Chan LS, Wang T, Wang X-S, Hammerberg C, Cooper KD: High frequency of HLA-DQB1 *0301 allele in patients with pure ocular cicatricial pemphigoid, Dermatology, 189 (suppl 1): 99-101, 1994.
35. Drouet M, Delpuget-Bertin N, Vaillant L, et al: HLA-DRB1 and HLA-DQB1 genes in susceptibility and resistance to cicatricial pemphigoid in French Caucasians, Eur J Dermatol, 8: 330-333, 1998.